propranolol 's in vitro antihemolyzing effect is more pronounced in patients with acute myocardial infarction and angina pectoris as compared to normal subjects . antihemolyzing effect of propranolol is reduced if it is preceded by the administration of beta-adrenoblockers in myocardial infarction .
C0033497
propranolol
C0027051
myocardial infarction